Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults [Phase 2]
Phase 2 clinical trial evaluating alpha-linolenic acid-enriched nutrition to prevent cognitive decline in APOE4 older adults. The study is c…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research [NA]
This completed clinical trial update describes approaches for innovative cognitive impairment case finding and engagement to diversify parti…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease [Phase 3]
A Phase 3 clinical trial evaluating combined metabolic activator supplementation in Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Tennessee Alzheimer's Project
Clinical Trial Update: Vanderbilt University Medical Center is conducting the Tennessee Alzheimer's Project, a recruiting study focused on a…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011) [NA]
This document provides an update on a pivotal sensory stimulation study for Alzheimer's disease (Hope Study, CA-0011); the trial status is A…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device [NA]
An ongoing clinical trial evaluating patient experience with the MemorEM device in several neurological diseases, with enrollment by invitat…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Use of Wearables for Identifying Factors Associated With Mild Cognitive Impairment and Early-Stage Alzheimer's Disease
A clinical trial studying wearable sensors to identify factors linked to mild cognitive impairment and early-stage Alzheimer's disease; the …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Retinal Imaging in Neurodegenerative Disease
This clinical trial update notes a Duke University-sponsored study evaluating retinal imaging as a biomarker across multiple neurodegenerati…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Benefits of Strength Training in Informal Caregivers of Patients With Alzheimer's Disease [NA]
This clinical trial update describes a study evaluating whether a strength-training program for informal caregivers of people with Alzheimer…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD) [NA]
A Georgia State University-led clinical trial is evaluating perturbation training to reduce falls in people with Alzheimer disease. The stud…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
A Mayo Clinic-led clinical trial is currently recruiting participants to study neurodegeneration and neuronal fluctuations in Lewy body deme…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: The Locus Coeruleus, Norepinephrine and Cognitive Aging [NA]
This clinical trial in recruitment is studying the relationship between the locus coeruleus, norepinephrine, and cognitive aging in individu…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Quantification of Hsp90 in the Human Brain [NA]
A recruiting clinical study aims to quantify Hsp90 levels in the human brain to explore its role in Parkinson's disease, Alzheimer's disease…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Open-label Extension Study in Participants With Early Alzheimer's Disease [Phase 2]
This document details an open-label extension study (Phase 2) for participants with early Alzheimer's disease, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Cannabidiol Medication Intervention Trial [Phase 2]
A Phase 2 clinical trial evaluating cannabidiol as an intervention for Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Senicapoc in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update on Senicapoc for Alzheimer's disease and mild cognitive impairment; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease [NA]
A Johns Hopkins University-sponsored clinical trial investigating cognitive vulnerability to stress in people at risk for Alzheimer's diseas…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Nabilone for Agitation Blinded Intervention Trial [Phase 3]
Phase 3 blinded trial of nabilone for agitation in Alzheimer disease is currently recruiting at Sunnybrook Health Sciences Centre.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Feasibility of Lecanemab Registry and Clinical Outcome Measures
Feasibility study assessing a lecanemab patient registry and the planned clinical outcome measures for Alzheimer’s disease.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial update for ONO-2020 in adults with mild to moderate Alzheimer's disease, noting the study is active but not current…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases [Phase 1, Phase 2]
Clinical trial update describing PET brain imaging studies in multiple sclerosis and Alzheimer's disease, as well as other neurological and …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Epileptic Hippocampus in Alzheimer's Disease [Phase 1, Phase 2]
A clinical trial update describes Phase 1 and Phase 2 investigations into epileptic activity in the hippocampus of Alzheimer's disease, spon…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK [Phase 1]
A Phase 1 trial evaluating NIO752's effect on tau synthesis in Alzheimer's disease, including autosomal dominant familial forms caused by PS…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)
The Monument Test is introduced as a new assessment tool to evaluate the ability to name and identify unique entities in Alzheimer’s disease…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease [Phase 1, Phase 2]
Clinical trial update on allogeneic adipose tissue-derived stem cells for Alzheimer’s disease in Phase 1/Phase 2; status is not yet recruiti…